These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6754156)

  • 1. The role of aldosterone in the response to treatment of primary hypertension.
    Weber MA; Drayer JI; Purdy RE; Laragh JH
    Clin Exp Hypertens A; 1982; 4(9-10):1923-34. PubMed ID: 6754156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.
    Drayer JI; Keim HJ; Weber MA; Case DB; Laragh JH
    Am J Med; 1976 May; 60(6):897-903. PubMed ID: 190882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparate patterns of aldosterone response during diuretic treatment of hypertension.
    Weber MA; Drayer JI; Rev A; Laragh JH
    Ann Intern Med; 1977 Nov; 87(5):558-63. PubMed ID: 921083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
    Drayer JI; Kloppenborg PW; Festen J; van't Laar A; Benraad TJ
    Am J Cardiol; 1975 Oct; 36(5):716-21. PubMed ID: 1103606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin reactivity as a determinant of responsiveness to antihypertensive treatment.
    Weber MA; Lopez-Ovejero JA; Drayer JI; Case DB; Laragh JH
    Arch Intern Med; 1977 Mar; 137(3):284-9. PubMed ID: 843146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of catecholamines and blood pressure to beta-blockade in diuretic-treated patients with essential hypertension.
    Meier A; Weidmann P; Ziegler WH
    Klin Wochenschr; 1982 Jan; 60(1):27-32. PubMed ID: 6122752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma renin activity does not predict the antihypertensive efficacy of chlorthalidone.
    Salvetti A; Pedrinelli R; Bartolomei G; Cagianelli MA; Cinotti G; Innocenti P; Loni C; Saba G; Saba P; Papi L
    Eur J Clin Pharmacol; 1987; 33(3):221-6. PubMed ID: 3319646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of clonidine and propranolol, separately and in combination, on blood pressure and plasma renin activity in essential hypertension.
    Weber MA; Drayer JI; Laragh JH
    J Clin Pharmacol; 1978; 18(5-6):233-40. PubMed ID: 641212
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma renin and "prorenin" in essential hypertension during sodium depletion, beta-blockade, and reduced arterial pressure.
    Atlas SA; Sealey JE; Laragh JH; Moon C
    Lancet; 1977 Oct; 2(8042):785-9. PubMed ID: 71600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on the renin-angiotensin system of agents acting at central and peripheral adrenergic receptors.
    Weber MA; Drayer JI; Hubbell FA
    Chest; 1983 Feb; 83(2 Suppl):374-7. PubMed ID: 6822130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
    Geyskes GG; Boer P; Vos J; Leenen FH; Mees EJ
    Circ Res; 1975 Jun; 36(6 Suppl 1):248-56. PubMed ID: 1093756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.
    Woods JW; Pittman AW; Pulliam CC; Werk EE; Waider W; Allen CA
    N Engl J Med; 1976 May; 294(21):1137-43. PubMed ID: 772425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
    Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
    J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
    Jaeger P; Brunner HR; Turini GA; Jéquier E; Ferguson RK; Gavras H
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1707-9. PubMed ID: 715407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension.
    Pedersen EB; Kornerup HJ; Pedersen OL; Andreasen F; Bjerregaard P
    Eur J Clin Pharmacol; 1981; 20(4):251-8. PubMed ID: 7030750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN; Zweifler AJ; Hansson L; Schork MA; Ellis C
    Aust N Z J Med; 1975 Feb; 5(1):17-24. PubMed ID: 1057909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of propranolol therapy on aldosterone responses to angiotensin II and adrenocorticotropic hormone in essential hypertension.
    Golub MS; Tuck ML; Fittingoff DB
    Clin Sci (Lond); 1981 Jul; 61(1):107-10. PubMed ID: 6265141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triamterene-induced changes in aldosterone and renin values in essential hypertension. Evidence of a role for aldosterone in preventing blood pressure reduction.
    Keim HJ; Drayer JI; Thurston H; Laragh JH
    Arch Intern Med; 1976 Jun; 136(6):645-8. PubMed ID: 1275620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol, renin and hypertension: a review.
    Laragh JH; Bühler FR
    Postgrad Med J; 1976; 52 Suppl 4(604):109-15. PubMed ID: 787950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pindolol: effects on blood pressure and plasma renin activity.
    Glassock RJ; Weitzman RE; Bennett CM; Maxwell M; Hamilton B; Winer N; Kirkendall W; Gonasun L
    Am Heart J; 1982 Aug; 104(2 Pt 2):421-5. PubMed ID: 7048878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.